Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of ROCK2 impedes osteoclastogenesis through Src-Ca2+-NFATc1 signaling pathway and alleviates ovariectomy-induced bone loss. | Int Immunopharmacol | 2026 | 41698297 | PubTator, text mining | PubMed |
| Cytotoxic CD4 T Cells: Dual Agents in HIV-1 Pathogenesis and Persistence. | Curr HIV/AIDS Rep | 2026 | 41697467 | PubTator, text mining | PubMed |
| SMARCA4 deficiency in glioblastoma: Mitochondrial transfer from MSCs and the clinical dilemma in targeting the tumor microenvironment. | Neoplasia | 2026 | 41692001 | PubTator, text mining | PubMed |
| Fasudil improves neutrophilic asthma by influencing M1 macrophage polarization and the expression of the NF-κB/TLR-2/RPS3 pathway. | Am J Transl Res | 2026 | 41676247 | PubTator, text mining | PubMed |
| Beyond cytoskeletal regulation: Rho-associated, coiled-coil-containing protein kinase 2 in kidney inflammation and fibrosis. | Histol Histopathol | 2026 | 41664601 | PubTator, text mining | PubMed |
| Opposing effects of Rho-associated coiled-coil kinase 1 (ROCK1) and ROCK2 in TGF-β-SMAD signaling. | Cell Commun Signal | 2026 | 41654799 | PubTator, text mining | PubMed |
| Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice. | Ann Hematol | 2026 | 41636858 | PubTator, text mining | PubMed |
| Evaluation of the Expression of Small Extracellular Vesicle Markers and Their Cargo in Treatment-Naïve Retinoblastoma Tumor Tissues. | Transl Vis Sci Technol | 2026 | 41590412 | PubTator, text mining | PubMed |
| Analysis of the impact of vertical deep hole blasting at the bottom of the hole on the lower ore body based on LS-dyna numerical simulation. | Sci Rep | 2026 | 41588181 | PubTator, text mining | PubMed |
| Organ Responses, Survival, and Safety of Belumosudil in Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-Analysis. | Clin Transplant | 2026 | 41556727 | PubTator, text mining | PubMed |
| A review of current therapeutics for psoriasis: Systemic and topical use of non-biological drugs. | Eur J Clin Pharmacol | 2026 | 41553544 | PubTator, text mining | PubMed |
| Focal Adhesion and Cancer Cell Cycle-Associated Resistance. | ACS Omega | 2026 | 41552449 | PubTator, text mining | PubMed |
| Peoniflorin Alleviates Corticotropin-Releasing Factor-Induced Irritable Bowel Syndrome by Improving the Intestinal Barrier Function through the Inhibition of the CRFR1/ROCK2/MLC Signaling Pathway. | J Agric Food Chem | 2026 | 41550014 | PubTator, text mining | PubMed |
| <p>Circ72309 modulates gemcitabine metabolism and gemcitabine sensitivity in pancreatic cancer: Serum Circ72309 levels as a potential predictor of treatment response</p>. | Int J Oncol | 2026 | 41543155 | PubTator, text mining | PubMed |
| MiR-324-5p mitigates experimental acute pancreatitis by suppressing Rock2 expression. | Mamm Genome | 2026 | 41526701 | PubTator, text mining | PubMed |
| Pharmacological profile and therapeutic evaluation of ROC-101, a potent and selective ROCK inhibitor, in arterial hypertension and pulmonary fibrosis. | Pharmacol Res | 2026 | 41371481 | PubTator, text mining | PubMed |
| Significant Antispastic Effect of Combined Fasudil and Isosorbide Dinitrate on Internal Mammary Artery in Coronary Artery Bypass Grafting. | Basic Clin Pharmacol Toxicol | 2026 | 41339615 | PubTator, text mining | PubMed |
| Harnessing ROCK biology to revolutionize diabetic nephropathy: decoding mechanisms, designing therapies. | Diabetol Int | 2026 | 41311514 | PubTator, text mining | PubMed |
| Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-Analysis. | Transplant Cell Ther | 2026 | 41241260 | PubTator, text mining | PubMed |
| LncRNA THUMPD3-AS1 Regulates Behavioral and Synaptic Structural Abnormalities in Schizophrenia via miR-485-5p and ARHGAP8. | Adv Sci (Weinh) | 2026 | 41168987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=5